Your browser doesn't support javascript.
loading
The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy's Cancer Centre.
Russell, Beth; Moss, Charlotte; Tsotra, Eirini; Gousis, Charalampos; Josephs, Debra; Enting, Deborah; Karampera, Christina; Khan, Muhammad; Roca, Jose; Sita-Lumsden, Ailsa; Owczarczyk, Kasia; Wylie, Harriet; Haire, Anna; Smith, Daniel; Zaki, Kamarul; Swampillai, Angela; Lei, Mary; Manik, Vishal; Michalarea, Vasiliki; Kristeleit, Rebecca; Mera, Anca; Sawyer, Elinor; Flanders, Lucy; De Francesco, Irene; Papa, Sophie; Ross, Paul; Spicer, James; Dann, Bill; Jogia, Vikash; Shaunak, Nisha; Kristeleit, Hartmut; Rigg, Anne; Montes, Ana; Van Hemelrijck, Mieke; Dolly, Saoirse.
Afiliação
  • Russell B; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
  • Moss C; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
  • Tsotra E; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Gousis C; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Josephs D; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Enting D; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Karampera C; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Khan M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Roca J; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Owczarczyk K; Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Wylie H; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
  • Haire A; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
  • Smith D; Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Zaki K; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Swampillai A; Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Lei M; Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Manik V; Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Michalarea V; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Kristeleit R; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Mera A; Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Sawyer E; Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Flanders L; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • De Francesco I; Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Papa S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Ross P; Immunoengineering Group, King's College London, London SE1 9RT, UK.
  • Spicer J; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Dann B; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Jogia V; Pharmacy, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Shaunak N; Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Kristeleit H; Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Rigg A; Pharmacy, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Montes A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Van Hemelrijck M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
  • Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 9RT, UK.
Cancers (Basel) ; 14(2)2022 Jan 06.
Article em En | MEDLINE | ID: mdl-35053432
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido